TP53 and small cell lung carcinoma: SCLC is most notably characterized by loss of RB1 and P53, both of which regulate various metabolic pathways (Table 1) (28, 73–75), therefore the observation of metabolic differences based on these alone would not provide unique and targetable pathways.